共 106 条
[31]
2-E
[32]
MATHEMATICAL-MODEL FOR INVIVO PHARMACODYNAMICS INTEGRATING FLUCTUATION OF THE RESPONSE - APPLICATION TO THE PROLACTIN SUPPRESSANT EFFECT OF THE DOPAMINOMIMETIC DRUG DCN 203-922
[J].
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS,
1991, 19 (03)
:287-309
[34]
PRIORI LITHIUM DOSAGE REGIMEN USING POPULATION CHARACTERISTICS OF PHARMACOKINETIC PARAMETERS
[J].
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS,
1979, 7 (06)
:579-628
[36]
Gelman A, 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411
[37]
Gieschke R, 1997, INT J CLIN PHARM TH, V35, P469
[38]
Girard P, 1998, STAT MED, V17, P2313, DOI 10.1002/(SICI)1097-0258(19981030)17:20<2313::AID-SIM935>3.0.CO
[39]
2-V